Before stepping into the business of medical technology, Luxbright chief executive Greg Carson was a partner at Gothenburg-based fund GU Ventures. The firm had invested in several companies in the field, giving the Californian investor an intimate view of the opportunity that lay ahead.
It was through these interactions that he met Dr Qiu-Hong Hu, who had been working with different technologies like field emissions and material science.
“I built a relationship with Dr Hu,” he explained, “and said we need to do something because his science is quite good.” Dr Hu is a 20-year expert in field emissions and material science, and holds 15 patents in these disciplines as well as being a former chief scientist at Swedish cleantech company Lightlab.
Soon, the duo began a market study to see what sectors and applications could benefit from this knowledge. “What’s a sector that needs a lot of innovation? That